{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:54:12Z","timestamp":1768874052991,"version":"3.49.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00712","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T04:40:15Z","timestamp":1588048815000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Tracking of an Oral Salmonella-Based Vaccine for Type 1 Diabetes in Non-obese Diabetic Mice"],"prefix":"10.3389","volume":"11","author":[{"given":"Jacques C.","family":"Mbongue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Alhoshani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Rawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo A.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Ferreri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fouad","family":"Kandeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed I.","family":"Husseiny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a007641","article-title":"The pathogenesis and natural history of type 1 diabetes.","volume":"2","author":"Atkinson","year":"2012","journal-title":"Cold Spring Harb Perspect Med."},{"key":"B2","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1172\/JCI31368","article-title":"Priming and effector dependence on insulin B:9\u201323 peptide in NOD islet autoimmunity.","volume":"117","author":"Nakayama","year":"2007","journal-title":"J Clin Invest."},{"key":"B3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1172\/JCI200421307","article-title":"Mature high\u2013affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes.","volume":"114","author":"Achenbach","year":"2004","journal-title":"J Clin Investigat"},{"key":"B4","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.2337\/db11-1520","article-title":"Circulating preproinsulin signal peptide\u2013specific CD8 T cells restricted by the susceptibility molecule HLA\u2013A24 are expanded at onset of type 1 diabetes and kill beta\u2013cells.","volume":"61","author":"Kronenberg","year":"2012","journal-title":"Diabetes"},{"key":"B5","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI35449C1","article-title":"CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose\u2013regulated preproinsulin epitope (vol 118, pg 3390, 2008).","volume":"119","author":"Skowera","year":"2009","journal-title":"J Clin Investigat."},{"key":"B6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ijmm.2007.08.006","article-title":"Rational design of Salmonella recombinant vaccines.","volume":"298","author":"Cheminay","year":"2008","journal-title":"Int J Med Microbiol."},{"key":"B7","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.4049\/jimmunol.174.5.2892","article-title":"Intracellular Salmonella inhibit antigen presentation by dendritic cells.","volume":"174","author":"Cheminay","year":"2005","journal-title":"J Immunol"},{"key":"B8","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.4049\/jimmunol.177.4.2224","article-title":"Salmonella typhimurium infection in nonobese diabetic mice generates immunomodulatory dendritic cells able to prevent type 1 diabetes.","volume":"177","author":"Raine","year":"2006","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/IAI.01066-08","article-title":"Interleukin\u201315 and NK1.1+ cells provide innate protection against acute Salmonella enterica serovar Typhimurium infection in the gut and in systemic tissues.","volume":"77","author":"Ashkar","year":"2009","journal-title":"Infect Immun."},{"key":"B10","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.vaccine.2014.02.070","article-title":"An oral vaccine for type 1 diabetes based on live attenuated Salmonella.","volume":"32","author":"Husseiny","year":"2014","journal-title":"Vaccine."},{"key":"B11","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/ijc.24957","article-title":"Novel cancer vaccine based on genes of Salmonella pathogenicity island 2.","volume":"126","author":"Xiong","year":"2010","journal-title":"Int J Cancer"},{"key":"B12","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1016\/j.vaccine.2004.11.035","article-title":"Evaluation of an intracellular\u2013activated promoter for the generation of live Salmonella recombinant vaccines.","volume":"23","author":"Husseiny","year":"2005","journal-title":"Vaccine"},{"key":"B13","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1128\/IAI.00298-10","article-title":"Efficacy of intracellular activated promoters for generation of Salmonella\u2013based vaccines.","volume":"78","author":"Xu","year":"2010","journal-title":"Infect Immun."},{"key":"B14","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1286-4579(01)01411-3","article-title":"Salmonella pathogenicity islands encoding type III secretion systems.","volume":"3","author":"Hansen\u2013Wester","year":"2001","journal-title":"Microbes Infect"},{"key":"B15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.cellbio.17.1.53","article-title":"Salmonella interactions with host cells: type III secretion at work.","volume":"17","author":"Galan","year":"2001","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1099\/mic.0.058115-0","article-title":"Functions of the Salmonella pathogenicity island 2 (SPI\u20132) type III secretion system effectors.","volume":"158","author":"Figueira","year":"2012","journal-title":"Microbiol SGM"},{"key":"B17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1538\/expanim.55.405","article-title":"In vitro and in vivo stability of plasmids in attenuated Salmonella enterica serovar typhimurium used as a carrier of DNA vaccine is associated with its replication origin.","volume":"55","author":"Haga","year":"2006","journal-title":"Exp Anim Tokyo"},{"key":"B18","first-page":"281","article-title":"Subunit vaccine construction using Salmonella enterica cells as a carrier of heterologous genes.","volume":"52","author":"Laniewski","year":"2013","journal-title":"Postep Mikrobiol."},{"key":"B19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1462-5822.2006.00706.x","article-title":"Manipulating cellular transport and immune responses: dynamic interactions between intracellular Salmonella enterica and its host cells.","volume":"8","author":"Abrahams","year":"2006","journal-title":"Cell Microbiol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033220","article-title":"Divergent roles of Salmonella pathogenicity island 2 and metabolic traits during interaction of S. enterica serovar typhimurium with host cells.","volume":"7","author":"Holzer","year":"2012","journal-title":"PLoS One."},{"key":"B21","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1128\/IAI.71.8.4664-4673.2003","article-title":"Construction, characterization, and immunogenicity of an attenuated Salmonella enterica serovar typhimurium pgtE vaccine expressing fimbriae with integrated viral epitopes from the spiC promoter.","volume":"71","author":"Chen","year":"2003","journal-title":"Infect Immun"},{"key":"B22","doi-asserted-by":"crossref","first-page":"19414","DOI":"10.1073\/pnas.1217554109","article-title":"Turning self\u2013destructing Salmonella into a universal DNA vaccine delivery platform.","volume":"109","author":"Kong","year":"2012","journal-title":"P Natl Acad Sci USA"},{"key":"B23","doi-asserted-by":"crossref","first-page":"8008","DOI":"10.1016\/j.vaccine.2018.10.101","article-title":"Factors affecting Salmonella\u2013based combination immunotherapy for prevention of type 1 diabetes in non\u2013obese diabetic mice.","volume":"36","author":"Husseiny","year":"2018","journal-title":"Vaccine."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3389\/fmicb.2014.00781","article-title":"Salmonella enterica serovar Senftenberg human clinical isolates lacking SPI\u20131.","volume":"46","author":"Hu","year":"2008","journal-title":"J Clin Microbiol"},{"key":"B25","article-title":"Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance.","volume":"5","author":"Chistiakov","year":"2014","journal-title":"Front Microbiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1189\/jlb.0307144","article-title":"The impact of cell\u2013bound antigen transport on mucosal tolerance induction.","volume":"82","author":"Pabst","year":"2007","journal-title":"J Leuk Biol."},{"key":"B27","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1097\/MOT.0b013e32833f7114","article-title":"Negative vaccination by tolerogenic dendritic cells in organ transplantation.","volume":"15","author":"Hill","year":"2010","journal-title":"Curr Opin Organ Tran."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00569","article-title":"Tolerogenic dendritic cells for regulatory T cell induction in man.","volume":"6","author":"Raker","year":"2015","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1182\/blood-2011-08-377416","article-title":"Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC\u201310 requires the IL\u201310\u2013dependent ILT4\/HLA\u2013G pathway (vol 116, pg 935, 2010).","volume":"118","author":"Gregori","year":"2011","journal-title":"Blood."},{"key":"B30","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1074-7613(03)00113-4","article-title":"Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo.","volume":"18","author":"Wakkach","year":"2003","journal-title":"Immunity."},{"key":"B31","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.4049\/jimmunol.1601045","article-title":"IL\u201310 receptor signaling is essential for T(R)1 cell function in vivo.","volume":"198","author":"Brockmann","year":"2017","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-662-43492-5_3","article-title":"Tr1 cells and the counter\u2013regulation of immunity: natural mechanisms and therapeutic applications.","volume":"380","author":"Roncarolo","year":"2014","journal-title":"Int Health Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000327265","article-title":"The proportion of regulatory T cells in the peripheral blood reflects the relapse or remission status of patients with Churg\u2013Strauss syndrome.","volume":"155","author":"Saito","year":"2011","journal-title":"Int Arch Allerg Immunol"},{"key":"B34","doi-asserted-by":"crossref","first-page":"10443","DOI":"10.1073\/pnas.1705599114","article-title":"Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development.","volume":"114","author":"Yu","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B35","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance.","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-3083.2011.02549.x","article-title":"Density of CD163+ CD11c+ dendritic cells increases and CD103+ dendritic cells decreases in the coeliac lesion.","volume":"74","author":"Beitnes","year":"2011","journal-title":"Scand J Immunol"},{"key":"B37","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1084\/jem.20040662","article-title":"Essential role for CD103 in the T cell\u2013mediated regulation of experimental colitis.","volume":"202","author":"Annacker","year":"2005","journal-title":"J Exp Med."},{"key":"B38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/mi.2009.13","article-title":"Intestinal epithelial cells promote colitis\u2013protective regulatory T\u2013cell differentiation through dendritic cell conditioning.","volume":"2","author":"Iliev","year":"2009","journal-title":"Mucosal Immunol."},{"key":"B39","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1084\/jem.20091925","article-title":"Intestinal CD103(+), but not CX3CR1(+), antigen sampling cells migrate in lymph and serve classical dendritic cell functions.","volume":"206","author":"Schulz","year":"2009","journal-title":"J Exp Med."},{"key":"B40","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/eji.200636426","article-title":"A distinct subset of intestinal dendritic cells responds selectively to oral TLR7\/8 stimulation.","volume":"36","author":"Yrlid","year":"2006","journal-title":"Eur J Immunol"},{"key":"B41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.0105-2896.2009.00866.x","article-title":"Subsets of migrating intestinal dendritic cells.","volume":"234","author":"Milling","year":"2010","journal-title":"Immunol Rev."},{"key":"B42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/biot.201400821","article-title":"Optimized sleeping beauty transposons rapidly generate stable transgenic cell lines.","volume":"10","author":"Kowarz","year":"2015","journal-title":"Biotechnol J"},{"key":"B43","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0092-8674(93)90458-3","article-title":"Molecular mechanisms of transposition and its control.","volume":"74","author":"Plasterk","year":"1993","journal-title":"Cell."},{"key":"B44","first-page":"787","article-title":"The ins and outs of transposition. Molecular mechanisms of transposition and its control, sponsored by the European molecular biology organization, roscoff, France, June 24\u201328, 1990.","volume":"2","author":"Plasterk","year":"1990","journal-title":"New Biol"},{"key":"B45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00320","article-title":"Reversal of new onset type 1 diabetes by oral Salmonella\u2013based combination therapy and mediated by regulatory T\u2013cells in NOD mice.","volume":"10","author":"Mbongue","year":"2019","journal-title":"Front Immunol."},{"key":"B46","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ng.343","article-title":"Molecular evolution of a novel hyperactive sleeping beauty transposase enables robust stable gene transfer in vertebrates.","volume":"41","author":"Mates","year":"2009","journal-title":"Nat Genet."},{"key":"B47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.vaccine.2005.11.020","article-title":"Recombinant vaccines based on translocated effector proteins of Salmonella pathogenicity Island 2.","volume":"25","author":"Husseiny","year":"2007","journal-title":"Vaccine"},{"key":"B48","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1172\/JCI60530","article-title":"Reversal of autoimmune diabetes by restoration of antigen\u2013specific tolerance using genetically modified Lactococcus lactis in mice.","volume":"122","author":"Takiishi","year":"2012","journal-title":"J Clin Invest."},{"key":"B49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1600-065X.2010.00981.x","article-title":"Cellular aspects of immunity to intracellular Salmonella enterica.","volume":"240","author":"Jantsch","year":"2011","journal-title":"Immunol Rev."},{"key":"B50","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1093\/nar\/gks1305","article-title":"Sleeping Beauty transposon\u2013based system for cellular reprogramming and targeted gene insertion in induced pluripotent stem cells.","volume":"41","author":"Grabundzija","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"B51","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1089\/hum.2009.109","article-title":"Stable transgene expression in primitive human CD34+ hematopoietic stem\/progenitor cells, using the Sleeping Beauty transposon system.","volume":"20","author":"Sumiyoshi","year":"2009","journal-title":"Hum Gene Ther."},{"key":"B52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/imr.12137","article-title":"A new approach to gene therapy using sleeping beauty to genetically modify clinical\u2013grade T cells to target CD19.","volume":"257","author":"Singh","year":"2014","journal-title":"Immunol Rev."},{"key":"B53","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity.","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature."},{"key":"B54","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2337\/db10-1201","article-title":"Defective differentiation of regulatory FoxP3(+) T cells by small\u2013intestinal dendritic cells in patients with type 1 diabetes.","volume":"60","author":"Badami","year":"2011","journal-title":"Diabetes"},{"key":"B55","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1084\/jem.20051100","article-title":"Functional specialization of gut CD103+ dendritic cells in the regulation of tissue\u2013selective T cell homing.","volume":"202","author":"Johansson\u2013Lindbom","year":"2005","journal-title":"J Exp Med."},{"key":"B56","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1038\/mi.2008.43","article-title":"CD103(+) GALT DCs promote Foxp3(+) regulatory T cells.","volume":"1","author":"Siddiqui","year":"2008","journal-title":"Mucosal Immunol."},{"key":"B57","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.immuni.2013.01.009","article-title":"Luminal bacteria recruit CD103(+) dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation.","volume":"38","author":"Farache","year":"2013","journal-title":"Immunity."},{"key":"B58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cellimm.2014.05.006","article-title":"The PD\u20131\/PD\u2013Ls pathway and autoimmune diseases.","volume":"290","author":"Dai","year":"2014","journal-title":"Cell Immunol"},{"key":"B59","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4049\/jimmunol.173.2.945","article-title":"SHP\u20131 and SHP\u20132 associate with immunoreceptor tyrosine\u2013based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation.","volume":"173","author":"Chemnitz","year":"2004","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12026-013-8448-1","article-title":"Autoimmune effector memory T cells: the bad and the good.","volume":"57","author":"Devarajan","year":"2013","journal-title":"Immunol Res."},{"key":"B61","article-title":"Induction of autoimmune disease by deletion of CTLA\u20134 in mice in adulthood.","volume":"46","author":"Klocke","year":"2016","journal-title":"Eur J Immunol."},{"key":"B62","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.19.1.225","article-title":"Complexities of CD28\/B7: CTLA\u20134 costimulatory pathways in autoimmunity and transplantation.","volume":"19","author":"Salomon","year":"2001","journal-title":"Annu Rev Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1600-065X.2008.00662.x","article-title":"Control of peripheral T\u2013cell tolerance and autoimmunity via the CTLA\u20134 and PD\u20131 pathways.","volume":"224","author":"Fife","year":"2008","journal-title":"Immunol Rev."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.autrev.2013.07.002","article-title":"CTLA\u20134 and autoimmunity: New insights into the dual regulator of tolerance.","volume":"12","author":"Romo\u2013Tena","year":"2013","journal-title":"Autoimmun Rev."},{"key":"B65","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jcmgh.2015.12.009","article-title":"Contribution of mesenteric lymph nodes and GALT to the intestinal Foxp3+ regulatory T\u2013cell compartment.","volume":"2","author":"Geem","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"B66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20011341","article-title":"Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen\u2013specific protection of mice from autoimmunity.","volume":"195","author":"Menges","year":"2002","journal-title":"J Exp Med"},{"key":"B67","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1471-4906(02)02281-0","article-title":"Immature, semi\u2013mature and fully mature dendritic cells: which signals induce tolerance or immunity?","volume":"23","author":"Lutz","year":"2002","journal-title":"Trends Immunol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00712\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T20:17:04Z","timestamp":1722802624000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00712\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2020.00712"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00712","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"article-number":"712"}}